AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6292013 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 8
Study 31944628 — intervention group
Group type: EXPERIMENTAL
Intervention: SZC 5 g once-daily during maintenance phase (MP)
Number of subjects: 267
Study 31944628 — intervention group
Group type: EXPERIMENTAL
Intervention: SZC 10 g once-daily during maintenance phase (MP)
Number of subjects: 267
Study 31944628 — intervention group
Group type: COMPARATOR
Intervention: Placebo during maintenance phase (MP)
Number of subjects: 267
Study 31642037 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexanolone injection
Number of subjects: 0
Study 31642037 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study 28753179 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted feeding intervention incorporating operant conditioning or systematic desensitization with immersive parent training.
Number of subjects: 98
Study 28753179 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention (10 sessions in a week) for MC group.
Number of subjects: 98
Study 28753179 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly intervention (10 sessions during 10 weeks) for MC group.
Number of subjects: 98
Study 28753179 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapy protocols (operant conditioning and systematic desensitization).
Number of subjects: 98
Study 25694509 — intervention group
Group type: EXPERIMENTAL
Intervention: High sensitivity troponin T (HsTnT) at baseline
Number of subjects: 830
Study 25694509 — intervention group
Group type: EXPERIMENTAL
Intervention: High sensitivity troponin T (HsTnT) after 24h
Number of subjects: 830
Study 25694509 — intervention group
Group type: EXPERIMENTAL
Intervention: High sensitivity troponin T (HsTnT) after 72h
Number of subjects: 830
Study 25694509 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 830
Study 25694509 — intervention group
Group type: EXPERIMENTAL
Intervention: Killip Class >1
Number of subjects: 830
Study 25159236 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate open repair
Number of subjects: 2226
Study 25159236 — intervention group
Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 2226
Study 22297597 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal therapy (NSPT)
Number of subjects: 30
Study 22297597 — intervention group
Group type: COMPARATOR
Intervention: Healthy group
Number of subjects: 30
Study 22297597 — intervention group
Group type: COMPARATOR
Intervention: Gingivitis group
Number of subjects: 30
Study 22297597 — intervention group
Group type: COMPARATOR
Intervention: Periodontitis group
Number of subjects: 30
Study 20191922 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based recruitment strategies including generalized mailings and personalized strategies such as personal office visits, letters, and faxes.
Number of subjects: 205
Study 20191922 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 205
Study 17565476 — intervention group
Group type: EXPERIMENTAL
Intervention: Port stapling using the 'Velocity' device
Number of subjects: 23
Study 17565476 — intervention group
Group type: COMPARATOR
Intervention: Conventional titanium‐port implantation
Number of subjects: 23
Study 16215308 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilboestrol (DES) 1 mg/day with 75 mg of aspirin
Number of subjects: 58
Study 16215308 — intervention group
Group type: COMPARATOR
Intervention: Bicalutamide 50 mg/day
Number of subjects: 58
Study 11498451 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg daily for 1 month)
Number of subjects: 6
Study 11498451 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum from raloxifene phase
Number of subjects: 6
Study 11498451 — intervention group
Group type: COMPARATOR
Intervention: Placebo phase
Number of subjects: 6
Study 9778008 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep cervical plexus block with 20 ml bupivacaine, 0.375%
Number of subjects: 40
Study 9778008 — intervention group
Group type: COMPARATOR
Intervention: Superficial cervical plexus block with 20 ml bupivacaine, 0.375%
Number of subjects: 40
Study 8164824 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone per day
Number of subjects: 96
Study 8164824 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg dexamethasone per day
Number of subjects: 96
Study 8164824 — intervention group
Group type: COMPARATOR
Intervention: 16 mg dexamethasone per day
Number of subjects: 96
Study 3408828 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural injection of 80 mg methylprednisolone in 10 ml physiological saline
Number of subjects: 39
Study 3408828 — intervention group
Group type: COMPARATOR
Intervention: Interspinous injection of 2 ml physiological saline
Number of subjects: 39
Study 31353217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Preventive Treatment (IPT) with dihydroartemisinin-piperaquine (4 and 18 mg/kg per day)
Number of subjects: 2279
Study 31353217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Screening and Treatment (IST) with monthly malaria rapid diagnostic tests
Number of subjects: 2279
Study 31353217 — intervention group
Group type: COMPARATOR
Intervention: Single Screening and Treatment (SST)
Number of subjects: 2279
Study 28839342 — intervention group
Group type: EXPERIMENTAL
Intervention: VBZ 80 mg
Number of subjects: 205
Study 28839342 — intervention group
Group type: EXPERIMENTAL
Intervention: VBZ 40 mg
Number of subjects: 205
Study 28839342 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 205
Study 25355243 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (MR-blockade)
Number of subjects: 101
Study 25355243 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 101
Study 24266552 — intervention group
Group type: EXPERIMENTAL
Intervention: Active analgesic strategy with pre-medication with oral midazolam mixture and intravenous alfentanil and midazolam regularly administered during the procedure
Number of subjects: 80
Study 24266552 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with morphine and diazepam (control group)
Number of subjects: 80
Study 24266552 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) ablation
Number of subjects: 80
Study 24266552 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryo balloon ablation
Number of subjects: 80
Study 24266552 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender differences in pain perception
Number of subjects: 80
Study 20685015 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein protein meal (CAPM)
Number of subjects: 22
Study 20685015 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein meal (SOPM)
Number of subjects: 22
Study 19674901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure (LBPP)
Number of subjects: 12
Study 19674901 — intervention group
Group type: COMPARATOR
Intervention: Harness system (LiteGait)
Number of subjects: 12
Study 17598698 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (test)
Number of subjects: 36
Study 17598698 — intervention group
Group type: COMPARATOR
Intervention: Commercially available original preparation (reference)
Number of subjects: 36
Study 15488867 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in triglycerides (n=19, median: -18 mg/dl)
Number of subjects: 39
Study 15488867 — intervention group
Group type: COMPARATOR
Intervention: Increase in triglycerides (n=20, median: +44 mg/dl)
Number of subjects: 39
Study 11125269 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.1% indomethacin solution
Number of subjects: 145
Study 11125269 — intervention group
Group type: COMPARATOR
Intervention: Topical 0.1% dexamethasone solution
Number of subjects: 145
Study 9443652 — intervention group
Group type: EXPERIMENTAL
Intervention: RCU patients (n = 24)
Number of subjects: 155
Study 9443652 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (n = 12)
Number of subjects: 155
Study 9443652 — intervention group
Group type: EXPERIMENTAL
Intervention: RCU patients (n = 119)
Number of subjects: 155
Study 8393585 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during gastroscopy
Number of subjects: 32
Study 8393585 — intervention group
Group type: COMPARATOR
Intervention: No music during gastroscopy
Number of subjects: 32
Study 3607096 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback (BF) trained group
Number of subjects: 21
Study 3607096 — intervention group
Group type: COMPARATOR
Intervention: Deception (DEC) trained group
Number of subjects: 21
Study 3607096 — intervention group
Group type: COMPARATOR
Intervention: Nonfeedback (NF) trained group
Number of subjects: 21
Study 31416797 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe acute sleep restriction (4 hours time in bed for 5 nights)
Number of subjects: 27
Study 31416797 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild long-term sleep restriction (1.5 hours less sleep/night for 6 weeks)
Number of subjects: 27
Study 31416797 — intervention group
Group type: COMPARATOR
Intervention: Habitual sleep (9 hours time in bed for 5 nights in study 1; normal sleep duration in study 2)
Number of subjects: 27
Study 30051267 — intervention group
Group type: EXPERIMENTAL
Intervention: Time trade-off (TTO) technique
Number of subjects: 0
Study 30051267 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete-choice experiment (DCE) technique
Number of subjects: 0
Study 27871603 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic infusion of phenylephrine (100-μg/mL solution at 1 mL/min)
Number of subjects: 54
Study 27871603 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.9% isotonic sodium chloride solution)
Number of subjects: 54
Study 24150200 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca+MZn+D group (zinc, 15 mg/day + multivitamins; calcium, 500 mg/day; vitamin D, 30,000 IU/3 months)
Number of subjects: 119
Study 24150200 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca+D group (calcium, 500 mg/day; vitamin D, 30,000 IU/3 months)
Number of subjects: 119
Study 24150200 — intervention group
Group type: EXPERIMENTAL
Intervention: M+D group (multivitamins; vitamin D, 30,000 IU/3 months)
Number of subjects: 119
Study 24150200 — intervention group
Group type: COMPARATOR
Intervention: Ca+MZn+D group
Number of subjects: 119
Study 24150200 — intervention group
Group type: EXPERIMENTAL
Intervention: M+D group
Number of subjects: 119
Study 24150200 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca+D group
Number of subjects: 119
Study 22486143 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/kg i.v. and Ketamine 0.5 mg/kg i.v. (Group KD)
Number of subjects: 120
Study 22486143 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 0.5 mg/kg i.v. (Group D)
Number of subjects: 120
Study 22486143 — intervention group
Group type: COMPARATOR
Intervention: Ketamine 0.5 mg/kg i.v. (Group K)
Number of subjects: 120
Study 22486143 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group C)
Number of subjects: 120
Study 20649409 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azithromycin (6 biannual mass distributions)
Number of subjects: 0
Study 19011472 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (HDMP) therapy (30 mg/kg/d for 3 d then 20 mg/kg/d for 4 d)
Number of subjects: 28
Study 19011472 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (HDMP) therapy
Number of subjects: 28
Study 19011472 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 15738450 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention group (nutrition counseling, smoking cessation, increased physical activity, intensive blood pressure treatment)
Number of subjects: 11827
Study 15738450 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 11827
Study 15738450 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention group among smokers (63% of participants)
Number of subjects: 11827
Study 15738450 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention group among nonsmokers (37% of participants)
Number of subjects: 11827
Study 12925557 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril-based blood pressure-lowering regimen
Number of subjects: 6105
Study 10394517 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine embolization
Number of subjects: 51
Study 9012194 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto Adjust CPAP
Number of subjects: 12
Study 9012194 — intervention group
Group type: COMPARATOR
Intervention: Constant CPAP
Number of subjects: 12
Study 9012194 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep-time, sleep efficiency and sleep stages
Number of subjects: 12
Study 8101900 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic variceal banding ligation
Number of subjects: 103
Study 8101900 — intervention group
Group type: COMPARATOR
Intervention: Injection sclerotherapy
Number of subjects: 103
Study 3786346 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine chewing gum (2 mg)
Number of subjects: 12
Study 3786346 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine chewing gum (4 mg)
Number of subjects: 12
Study 3786346 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mg nicotine gum)
Number of subjects: 12
Study 29071356 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 125
Study 29071356 — intervention group
Group type: COMPARATOR
Intervention: Standard instrumentation (SI)
Number of subjects: 125
Study 27683846 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam (0.5 mg·kg‐1·d‐1, adjustable up to 2.0 mg·kg‐1·d‐1, maximum 80 mg/d)
Number of subjects: 200
Study 27683846 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam
Number of subjects: 200
Study 23837461 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (1 mg/kg/day titrated to 8 mg/kg/day over 8 weeks, maintained for 12 weeks)
Number of subjects: 207
Study 23837461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 23837461 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide
Number of subjects: 207
Study 20942843 — intervention group
Group type: EXPERIMENTAL
Intervention: Gem-(R)CHOP
Number of subjects: 25
Study 20942843 — intervention group
Group type: COMPARATOR
Intervention: (R)CHOP
Number of subjects: 25
Study 21299184 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai traditional massage (TTM)
Number of subjects: 18
Study 21299184 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese acupuncture
Number of subjects: 18
Study 17488363 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) 4 mg twice daily for 6 weeks
Number of subjects: 32
Study 17488363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15371860 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 72
Study 15371860 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (placebo)
Number of subjects: 72
Study 11354518 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of temazepam
Number of subjects: 17
Study 11354518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 9059318 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical oesophageal stimulation (200 microns, 16 mA, 0.2 Hz)
Number of subjects: 14
Study 9059318 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical oesophageal stimulation (0.5 s, 14 ml, 0.2 Hz)
Number of subjects: 14
Study 8126629 — intervention group
Group type: EXPERIMENTAL
Intervention: Curosurf (natural surfactant)
Number of subjects: 66
Study 8126629 — intervention group
Group type: COMPARATOR
Intervention: Exosurf (synthetic surfactant)
Number of subjects: 66
Study 3117877 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 31
Study 3117877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 30170410 — intervention group
Group type: EXPERIMENTAL
Intervention: Core Strength Training (CST) for 1 hour per day, 5 days per week for 12 weeks
Number of subjects: 384
Study 30170410 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) for 1 hour per day, 5 days per week for 12 weeks
Number of subjects: 384
Study 30170410 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CST and TCC for 30 minutes each per day, 5 days per week for 12 weeks
Number of subjects: 384
Study 30170410 — intervention group
Group type: COMPARATOR
Intervention: No specific exercises (Control group)
Number of subjects: 384
Study 26909882 — intervention group
Group type: EXPERIMENTAL
Intervention: LA Sprouts intervention
Number of subjects: 319
Study 26909882 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 319
Study 24210765 — intervention group
Group type: EXPERIMENTAL
Intervention: EX-PRESS
Number of subjects: 120
Study 24210765 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 120
Study 23435159 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal-bolus regimen with glargine once daily and glulisine before meals
Number of subjects: 375
Study 23435159 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal plus regimen with glargine once daily and supplemental doses of glulisine
Number of subjects: 375
Study 23435159 — intervention group
Group type: COMPARATOR
Intervention: Sliding scale regular insulin (SSI)
Number of subjects: 375
Study 20102616 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised clinical decision support (CCDS) software used by paramedics
Number of subjects: 60
Study 20102616 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 60
Study 19123335 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic dripping with Taihuang liquid (THL)
Number of subjects: 138
Study 19123335 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment and nursing (Control)
Number of subjects: 138
Study 16095766 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of SsWC on Days 0, 14, and 28 (N = 3)
Number of subjects: 10
Study 16095766 — intervention group
Group type: EXPERIMENTAL
Intervention: Five doses of SsWC on Days 0, 2, 4, 6, and 28 (N = 4)
Number of subjects: 10
Study 16095766 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 3)
Number of subjects: 10
Study 16095766 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dosing regimens of SsWC
Number of subjects: 10
Study 12912816 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (25 mg single dose)
Number of subjects: 0
Study 12912816 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (100 mg single dose)
Number of subjects: 0
Study 12912816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12912816 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (25 mg BID for 6 months)
Number of subjects: 0
Study 12912816 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (200 mg extended-release daily for 6 months)
Number of subjects: 0
Study 10792115 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg o.d.)
Number of subjects: 12
Study 10792115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10792115 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole/diclofenac
Number of subjects: 12
Study 10792115 — intervention group
Group type: COMPARATOR
Intervention: Placebo/diclofenac
Number of subjects: 12
Study 8852907 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent oral polio vaccine (OPV)
Number of subjects: 0
Study 2060435 — intervention group
Group type: EXPERIMENTAL
Intervention: d-fenfluramine (15 mg/day for 1 week)
Number of subjects: 20
Study 2060435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6689058 — intervention group
Group type: EXPERIMENTAL
Intervention: DSIP (delta-sleep-inducing-peptide)
Number of subjects: 0
Study 31021381 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonneovascular AMD in the fellow eye
Number of subjects: 686
Study 27790756 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene 0.1%/benzoyl peroxide 2.5% gel (A/BPO)
Number of subjects: 31
Study 27790756 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 31
Study 27477059 — intervention group
Group type: EXPERIMENTAL
Intervention: Average nightly sleep duration at 4th grade
Number of subjects: 709
Study 27477059 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory control (EF subdomain)
Number of subjects: 709
Study 27477059 — intervention group
Group type: EXPERIMENTAL
Intervention: Organization of materials (EF subdomain)
Number of subjects: 709
Study 27477059 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay of weekend bed‐ or wake‐times
Number of subjects: 709
Study 24310444 — intervention group
Group type: EXPERIMENTAL
Intervention: PULSED orosensory stimulation through a pneumatically charged pacifier
Number of subjects: 160
Study 24310444 — intervention group
Group type: COMPARATOR
Intervention: SHAM control (blind pacifier)
Number of subjects: 160
Study 24310444 — intervention group
Group type: EXPERIMENTAL
Intervention: PULSED orosensory stimulation
Number of subjects: 160
Study 22209048 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube cuff management
Number of subjects: 0
Study 19036353 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training plus concreteness training
Number of subjects: 2
Study 19036353 — intervention group
Group type: COMPARATOR
Intervention: Relaxation training
Number of subjects: 2
Study 17385938 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone in combination with estrogen
Number of subjects: 0
Study 17385938 — intervention group
Group type: COMPARATOR
Intervention: Oral progestogen preparations (control)
Number of subjects: 0
Study 15735107 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient (DMM) supplement
Number of subjects: 1134
Study 15735107 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly multiple micronutrient (WMM) supplement
Number of subjects: 1134
Study 15735107 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron (DI) supplements
Number of subjects: 1134
Study 15735107 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 1134
Study 11960302 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-restricted diet plan of 5.2-6.3 MJ/day with nutrient-fortified liquid meal replacement (MR) for group B.
Number of subjects: 100